Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant

Somatostatin exhibits an inhibitory effect on pituitary hormone secretion, including inhibition of growth hormone and adrenocorticotropic hormone (ACTH), and it can have antisecretory and antitumor effects on neuroendocrine tumors (NETs) that express somatostatin receptors. Although the precise mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Pivonello, Rosario, Munster, Pamela N., Terzolo, Massimo, Ferrigno, Rosario, Simeoli, Chiara, Puglisi, Soraya, Bali, Utsav, Moraitis, Andreas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764187/
https://www.ncbi.nlm.nih.gov/pubmed/35058882
http://dx.doi.org/10.3389/fendo.2021.793262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764187/
https://www.ncbi.nlm.nih.gov/pubmed/35058882
http://dx.doi.org/10.3389/fendo.2021.793262

Ejemplares similares